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Abstract 
Human smuggling and associated cross-border crimes have evolved as a major challenge for the 
European Union in recent years. Of particular concern is the increasing trend of smuggling migrants 
hidden inside shipping containers or trucks. Therefore, there is a growing demand for portable security 
devices for the non-intrusive and rapid monitoring of containers to detect people hiding inside. In this 
context, chemical analysis of volatiles organic compounds (VOCs) emitted from the human body is 
proposed as a locating tool. In the present study, an in-house made ion mobility spectrometer coupled 
with gas chromatography (GC-IMS) was used to monitor the volatile moieties released from the 
human body under conditions that mimic entrapment. A total of 17 omnipresent volatile compounds 
were identified and quantified from 35 ion mobility peaks corresponding to human presence. These 
are 7 aldehydes (acrolein, 2-methylpropanal, 3-methylbutanal, 2-ethacrolein, n-hexanal, n-heptanal, 
benzaldehyde), 3 ketones (acetone, 2-pentanone, 4-methyl-2-pentanone), 5 esters (ethyl formate, ethyl 
propionate, vinyl butyrate, butyl acetate, ethyl isovalerate), one alcohol (2-methyl-1-propanol) and one 
organic acid (acetic acid). The limits of detection (0.05 -7.2 ppb) and relative standard deviations (0.6-
11%) should be sufficient for detecting these markers of human presence in field conditions. This 
study shows that GC-IMS can be used as a portable field detector of hidden or entrapped people.  
 
 
 
 
 
 
 
 
Keywords: 
Volatile organic compounds, Ion Mobility Spectrometry, GC-IMS, entrapped victims, human 
smuggling, human occupancy detection 
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1. Introduction 
The trafficking and smuggling of people to Europe have reached epidemic proportions in recent years. 
According to estimates from the European Border and Coast Guard Agency (Frontex) more than 1.8 
million people entered Europe in 2015, taking into account also those who crossed European borders 
undetected[1]. Criminal networks have rapidly reacted to this development and substantially increased 
their involvement into migrant smuggling. Smugglers offer a wide range of services such as 
transportation, accommodation and fraudulent documents, often at excessively high prices, whilst 
putting at risk the health and lives of people being trafficked or smuggled. For example, in attempting 
to reach Europe via the Mediterranean route, between 2000 and 2015 more than 30,000 refugees are 
believed to have drowned or died from hypothermia and starvation[1]. Transport by road boosted a 
highly dangerous trend of smuggling migrants hidden inside containers or trucks. For example, on the 
27
th
 August, 2015, on a motorway between Neusiedl and Parndorf, Burgenland, Austria, 71 migrants 
were found suffocated in a refrigerated truck. In this context, the early detection and interception of 
smuggled people is of particular importance, not just to protect European borders, but also to save 
them from life-threatening and/or degrading situations. Consequently, there is a growing demand for 
highly portable, rapid security devices for non-intrusive monitoring of containers and trucks to detect 
the presence of hidden people. To be applicable, the time and costs of inspection play a fundamental 
role. Therefore, such an analytical tool should ideally be able to detect stowaways without the 
requirement of opening container doors and breaking custom’s seals. A number of approaches have 
been applied to detect humans. The most common one is the use of search-and-rescue (SAR) dogs. 
However, this is time-consuming because containers have to be opened and cargo taken out, because 
often migrants are burrowed deep in the cargo. Alternative tracking tools include CO2 sensors, thermal 
cameras, acoustic probes (aiming at voices or detecting heartbeats), or occasionally X-rays[2]. 
Interestingly, to date any chemical analysis that is capable of providing a human-specific chemical 
signature has received little attention, and is currently limited to the aforementioned carbon dioxide 
sensing. This is surprising as volatile organic compounds (VOCs) are often the products of vital 
metabolic pathways occurring in the human organism and they could therefore serve as signs-of-life.  
Indeed, a number of recent studies have provided evidence that some human-borne VOCs could be 
employed as markers of human presence and thereby support the detection of stowaways hidden inside 
shipping containers or trucks[3-5]. 
Ion mobility spectrometry (IMS) is a well-established sensitive technique in the analyst arsenal for 
volatile compounds chemical identification, and hence has a great potential in this context [6]. 
Currently, the main application area for IMS is in security (military and homeland) for the detection of 
chemical warfare agents and explosives. However, this technology has also proved to be useful in 
several other applications such as drugs detection/monitoring, air quality control, or monitoring of 
industrial processes[7-12]. This stems from its versatility, excellent sensitivity and real-time response. 
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IMS instruments are portable, robust, and relatively inexpensive compared to mass spectrometric 
instruments, have low energy consumption, and are capable of near-real time detection of human-
borne VOCs at ultra-low ppb (parts-per-billion) levels without sample pre-processing. The main 
drawback of the IMS instruments - limited selectivity - can be compensated via their coupling with gas 
chromatography, or liquid chromatography, although this comes at the price of increased analysis time 
[13, 14].  
Here we present a study of entrapped humans using an IMS coupled to gas chromatography (GC-
IMS). We illustrate its application to determine and monitor skin- and breath-borne VOCs released 
from the human body under conditions that mimic entrapment and provide details on its potential as a 
field deployable system to detect people in short time. 
2. Experimental 
 
2.1. Materials and calibration mixtures 
Multi-compound calibration mixtures were prepared from pure liquid substances. The reference 
substances, with purities ranging from 98 to 99.9%, were purchased from Sigma-Aldrich (Austria), 
Fluka (Switzerland), and SAFC (USA). The preparation of gaseous calibration mixtures has been 
described in detail elsewhere[15], and therefore only a brief outline of the procedure is provided here. 
Gaseous mixtures of species of interest were produced by means of a GasLab calibration mixtures 
generator (Breitfuss Messtechnik, Germany). The generator supports the preparation of gas mixtures at 
pre-defined humidity levels from pure liquid substances containing 10 ppb to 100 ppm of each solute. 
However, for this study, pure substances were additionally diluted at ratios of 1:2000-1:3000 to 
achieve lower concentration levels. Gas mixtures exhibiting analytes volume fractions ranging from 
0.1 to 1000 ppb were used for calibration and validation. Calibration curves were obtained on the basis 
of 3-fold analyses of 5, or 6 distinct and independent concentration levels. 
2.2. Human subjects 
A cohort of 11 healthy subjects (7 males, age range 19-59 years, 1 smoker) was recruited. All 
volunteers gave written informed consent to participate and completed a questionnaire describing their 
basic personal data and smoking status. The experiments were performed under light fasting 
conditions (minimum of 8 hours). Moreover, they were asked to refrain from alcohol consumption for 
12 hours prior to the experiment and from using cosmetics. The sample collection was approved by 
the Ethics Commission of Innsbruck Medical University. 
2.3. Body chamber and experimental protocol 
A detailed description of the experimental setup mimicking the entrapment is given elsewhere[16]. 
Therefore, only a short description will be provided here. A body plethysmography chamber 
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BodyScope (Ganshorn Medicin Electronic GmbH, Germany), with interior dimensions of 82×63×161 
cm
3
 (approximately 819 L) was used during experiments. The chamber was equipped with a fan 
installed at the ceiling assuring the homogenous mixing of the chamber air. A heated (40 ºC) Teflon 
transfer line connected the chamber with the sample loop (200 µL) of the GC-IMS instrument. The 
inlet of the transfer line was located in the centre of the side wall. The samples were introduced into 
the sample loop of the instrument using a pump that was turned-on shortly before sampling. At the 
onset of each measurement, the chamber and the laboratory room were vented for several hours to 
reduce the level of indoor contaminants. Each measurement consisted of three phases: (i) background 
phase (20 mins), (ii) skin emission phase (60 mins) and (iii) combined breath and skin emission phase 
(60 mins). During the first phase, two background measurements at 0 and 20 mins were performed. 
Immediately after the second background measurement, a volunteer entered the chamber and the 
chamber door was tightly locked. Each volunteer had only underwear on in order to allow a large skin 
area accessible. All volunteers remained inside the chamber for 2 hours in a seated position. During 
the first hour of the experiment only the skin-borne VOCs were targeted and the subjects freely 
inhaled and exhaled outside air via a silicone head mask (V2 Mask, Hans Rudolph inc., USA) and a 
two-way non-rebreathing Y shape-valve (Hans Rudolph inc., USA) connected with two flexible tubes 
(ID = 22 mm) to additional ports located on the side wall of the chamber. During the second hour, 
subjects exhaled directly into the chamber interior, while still inhaling outside air. This was achieved 
by disconnecting the outlet tube from the mask. Consequently, during this third phase, both breath- 
and skin-borne volatiles accumulated in the chamber. Altogether, a single experiment lasted 140 
minutes. The first air sample was drawn and analyzed immediately after a subject was enclosed in the 
chamber and the next ones were taken at 20 minute intervals.  
2.4. GC-IMS analysis 
VOCs were monitored using an in-house made high resolution GC-IMS developed at Leibniz 
Universität, Hannover. Samples were injected into the GC column using a stainless steel sample loop 
(200 µL) installed on a six-way valve. Volatiles were separated using a RTX volatiles column (10 
m×0.53 mm, film thickness 2 µm, Restek) working at constant temperature of 50°C. The carrier gas 
flow rate program was as follows: 2 ml min
-1
 for 10 minutes and then 10 ml min
-1
 for another 10 
minutes, resulting in a total GC-runtime of 20 minutes. The IMS, with a drift tube length of 7.5 cm, 
provided a resolving power of R = 90 using a drift voltage of 5 kV. The instrument operated at 40 °C, 
10 mbar above the ambient pressure and with the purified air as the drift gas at the flow of 150 mL 
min
-1. A radioactive β- emitter 3H (300 MBq) was used as the ionization source. The dimensions of the 
GC-IMS instruments are 45×45×28 cm
3
. A detailed description of the system can be found 
elsewhere [17]. 
The identification of compounds under scrutiny relied on the comparison of retention and drift times 
(ion mobilities) of ion mobility peaks with the respective libraries of retention times and drift times 
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obtained from standard mixtures. Here, quantification of all volatiles, with the exception of acetone, 
was based on monomer peaks. Owing to the high acetone levels, exceeding the dynamic range of the 
IMS instrument, quantification of this compound relied on the dimer ion peak. The variability of the 
drift and retention times was 1-1.3% and 0.5-5% respectively. Acetic acid exhibited higher variability 
of the retention time of 13.6%. The retention times, ion mobilities and method parameters of VOCs of 
interest are presented in Table 1. 
3. Results and discussion 
3.1. Method validation 
Limits of detection (LODs) were calculated using the standard deviation of 9 consecutive blank 
signals[18]. The LOD values ranged from 0.05 ppb (1.95 pmol L
-1
) for acetone to 7.2 ppb (0.28 
nmol L
-1
)
 
for acetic acid. These LODs are adequate for the detection of the majority of potential 
human volatile markers in the vicinity of a hidden person[5]. The limit of quantification (LOQ) was 
defined as 3×LOD. Relative standard deviations (RSDs) were calculated on the basis of consecutive 
analyses of 10 independent standard mixtures exhibiting concentrations close to the means of the 
observed levels in real samples. The RSDs fall within the range of 0.6-11.7%.  
 
3.2. VOCs resulting from human presence 
An exemplary chromatogram from a GC-IMS analysis of VOCs emitted by human body is shown in 
Fig. 1. More than 80 ion mobility peaks were found in the air of the chamber. Thirty-five of these were 
found to depend on the time of entrapment. Seventeen species from this set were found to be 
omnipresent and were reliably identified and quantified; 7 aldehydes (acrolein, 2-methylpropanal, 3-
methylbutanal, 2-ethacrolein, n-hexanal, n-heptanal, benzaldehyde), 3 ketones (acetone, 2-pentanone, 
4-methyl-2-pentanone), 5 esters (ethyl formate, ethyl propionate, vinyl butyrate, butyl acetate, ethyl 
isovalerate), one alcohol (2-methyl-1-propanol) and one organic acid (acetic acid). The mean 
concentrations of the VOCs of interest are in the range of 0.3-330 ppb (0.012 – 12.9 nmol L-1), as 
shown in Table 2. The highest mean levels (hundreds of ppb at the end of the entrapment time) were 
noted for acetone and acetic acid. Examples of the mean concentration profiles of acetone, 2-
ethacrolein, ethyl isovalerate, and vinyl butyrate are shown in Figure 2. All 17 compounds of interest 
were found to be released during the skin emission phase of the experiment, with only two of them, 
acetone and 2-ethacrolein, having a substantial breath component. Owing to the shortage of other 
studies it is difficult to verify the concentrations obtained within this study. Nevertheless, several 
concentration values can be found for some compounds under scrutiny (see Table 2). For instance, 
Risberg et al. [19] investigated VOCs emitted by a group of 18 volunteers enclosed in Ula-class 
submarine (250 m
3
), whereas, Guo et al.[20] analyzed human-borne contaminants in a simulated 
spacecraft module. In our previous paper [21]we quantified 60 skin-borne VOCs in confine spaces 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
7 
 
surrounding encapsulated hands and forearms of 31 volunteers. These results agree reasonably well 
with the levels reported here.  
Although the biochemical origins of human VOCs are uncertain, a number of sources could be 
responsible for their emission. These include (i) systemic production related to the physiological 
processes in the body, (ii) oxidation of human sebum [22-24], (iii) activity of microorganisms (e.g. 
skin and gut flora)[25, 26], (iv) environmental exposure (dirt, dust, cosmetics, detergents, smoking, 
etc.), and (v) diet and its metabolites. 
Three ketones were found to result from human presence. Acetone exhibited the highest levels 
amongst all compounds under study and was also found to be released by both skin and breath, with 
breath being the most dominant. This was manifested by a rapid increase of acetone levels during the 
breath and skin emission phase of the experiment. Acetone is the major VOC produced in the human 
organism exhibiting high abundances in breath [15, 27], blood [28], and urine [29, 30]. Several 
sources of acetone in human body can be listed. These are (i) endogenous decarboxylation of Acetyl–
CoA [27, 31], (ii) oxidative degradation of squalene on human skin [32], (iii) 2-propanol metabolism 
[33], and (iv) diet. However, the latter two are of minor importance. In the context of human detection, 
acetone’s high emission rates and systemic production render it a very important marker for human 
presence. Compared to acetone, the other ketones, 2-pentanone and 4-methyl-2-pentanone had much 
lower levels in the chamber air (reaching a maximum of 6.3 ppb at the end of the experiment). Their 
origin is unclear and may be a result of diet, environmental exposure, or secondary alcohols 
metabolism [34-36]. If so, 2-pentanone could stem from 2-pentanol, whereas, 4-methyl-2-pentanone 
from 4-methyl-2-pentanol [36]. 
Seven aldehydes increased in concentration as a result of human presence in the chamber. 
Interestingly, the concentrations of aldehydes tended to increase during the skin phase of the 
experiment (60 mins) and then stabilized during the last phase of the measurements. It is plausible to 
attribute this concentration dependence to the decrease of the aldehydes production during entrapment. 
The presence of aldehydes in human odor mirrors the O3- and UV-related oxidative stress on human 
skin inducing peroxidation of unsaturated fatty acids forming the human sebum. While exposed to 
reactive oxygen species, these fatty acids degrade releasing a number of VOCs including aldehydes 
[22-24]. More specifically, aldehydes are produced from skin fatty acids via β-scission of alkoxy 
radicals formed by the homolytic cleavage of hydroperoxides. For instance, n-hexanal was 
demonstrated to be formed from linoleic, palmitoleic and vaccenic acids [22, 24]. The isolation of an 
individual from the predominant factors inducing this condition (O3, UV) may hinder, or even 
suppress the skin production of the oxidative stress-related species. Acrolein emitted by the involved 
subjects is most probably an exogenous compound stemming from dietary or environmental 
sources[37]. It could also reflect the exposure to the tobacco smoke; however, only one volunteer was 
a smoker. The high background levels of acrolein seem to support the environmental origin of this 
specie. Further studies are necessary to confirm the usefulness of this compound for human location.   
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Regarding esters, the levels of 5 species were found to be dependent on a human’s presence in the 
chamber. Interestingly, within this class of compounds, different concentration profiles were observed. 
Ethyl propionate and vinyl butyrate exhibited profiles similar to those observed for aldehydes with 
rapid concentration increase during the skin emission phase and plateau during the last 60 mins of the 
volunteer presence in the chamber. Concentrations of ethyl isovalerate were characterized by 
increasing concentrations during the entrapment period. For ethyl formate and butyl acetate an 
increase in concentrations was observed during the skin phase measurements, followed by a decrease 
during the skin and breath phase. Owing to the limited knowledge on the endogenous origin of esters, 
it is difficult to explain the observed concentration profiles. Nevertheless, several possible sources can 
be suggested. Esters are typical ingredients of cosmetics or fragrances. Although volunteers were 
asked to refrain from using cosmetics on the day of the experiments, the observations could reflect 
prior exposure to these substances. Alternative sources for esters include (i) diet and its metabolites 
(natural occurrence e.g. in fruits, synthetic flavorings), (ii) environmental exposure (solvents), and (iii) 
peroxidation of unsaturated fatty acids [24]. Indeed, the observed concentration profiles of esters 
suggest a limited pool of these species in human body and their exogenous origin rather than a 
systemic production. 
Acetic acid is a common VOC resulting from normal human biochemistry (e.g. ethanol 
metabolism, Krebs cycle, or pyruvate metabolism) and hence released from the body via breath [38, 
39]. It can also be produced by cutaneous bacteria during the biotransformation of longer chain fatty 
acids and glycerol present in human sebum [26, 40]. Acetic acid was one of the most abundant 
compounds observed in the chamber air. It was emitted during both experimental phases. However, 
the breath contribution was not significant.  
Although this study provides encouraging results, in order to propose a set of VOCs that can 
be used as a unique human chemical "fingerprint" further studies are required including robustness and 
reliability assessment under field conditions (e.g. contaminated environment of shipping containers, 
presence of animals etc.) This requires the creation of specific libraries containing chemical patterns 
representative for shipping containers or trucks containing different cargos (including animals). 
Moreover, losses related to e.g. absorption on materials present in the containers such as clothing or 
dust, or the influence of factors such as temperature and humidity (inducing condensation and 
formation of water films) have to be carefully evaluated. All of these confounders may considerably 
distort the levels of the volatile species and hinder their value as distinct markers for human presence. 
Therefore, extensive testing under more realistic conditions is crucial. 
4. Conclusions 
In the context of an escalation of people smuggling and trafficking, there is a need for analytical tools 
for the rapid and non-intrusive inspection of containers to detect hidden people. We have 
demonstrated that a GC-IMS instrument has considerable potential for use in this field. Analytically it 
offers distinct advantages. Firstly, it exhibits excellent detection limits without the necessity for 
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sample pre-concentration or pre-processing. The LODs obtained within this study are of the order of 
several hundreds of ppt, which are more than satisfactory for the detection of the majority of potential 
markers of human presence in the vicinity of the hidden person[5]. Secondly, direct sample injection 
improves the quality and reliability of the results, as any sample pre-concentration can result in 
potential losses and contamination. Thirdly, the analysis does not require external carrier/drift gases, 
or additional consumables (assisting in its field applicability). Several limitations of the current GC-
IMS should be mentioned. Firstly, it is relatively large in size. This places some limitations on its use 
in field conditions. The prototype; however, has a modular design, which has a potential to be 
miniaturised. Another limitation is that some interesting classes of volatiles (e.g. alkanes) cannot be 
measured using the IMS technique. Furthermore, the current analysis time is too long to track 
concentration gradients, which could help to locate the victims. This; however, can be optimised in 
future application focussed on selected target markers. A major issue with IMS is its low temporal 
resolution. This leads to issues with compound identification.  
However, the major obstacle for the application of GC-IMS is not instrumental, but the identification 
of robust and reliable markers for entrapped people. Once they have been determined,  instrumental 
development can then take place to provide a customized, low-cost, and highly portable GC-IMS 
device for targeted analysis. In this context, it will be necessary to build a library of retention and drift 
times (mobilities), which could support the identification and monitoring of VOCs release by human 
body. This study has begun this process. 
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Table 1. Retention times Rt, reduced mobilities k0, LODs, RSDs and dynamic ranges of compounds under study. Compounds are ordered with respect to 
increasing retention time. 
Compound CAS Retention time, Rt 
[min] 
Reduced mobility, k0 
[cm
2
 V
-1
 s
-1
] 
LOD 
 
RSD 
[%] 
Dynamic range  
[ppb] [pmol L
-1
] [ppb] [pmol L
-1
] 
Acrolein  107-02-8 1.04 1.927 0.25 9.75 5.9 0.75-100 29-3900 
Acetone  67-64-1 1.18 1.768 0.05 1.95 1.3 0.15-1000 6.0-39000 
2-Methylpropanal 78-84-2 1.43 1.805 0.18 7.02 4.4 0.54-100 21-3900 
Ethyl formate 109-94-4 1.51 1.688 0.16 6.24 3.5 0.48-20 17.6-780 
2-Methyl-1-propanol 78-83-1 2.45 1.694 0.19 7.41 1.4 0.57-50 22-1950 
3-methylbutanal 590-86-3 2.47 1.686 0.05 1.95 1.7 0.15-100 5.9-3900 
2-Ethacrolein  922-63-4 2.92 1.793 0.23 8.97 4.6 0.69-50 27-1950 
Ethyl propionate  105-37-3 3.22 1.245 0.41 16.0 0.6 1.23-20 48-780 
Acetic acid  64-19-7 3.24 1.913 7.20 281 11.7 22-400 860-15600 
2-pentanone  107-87-9 3.35 1.826 0.07 2.73 7.5 0.21-20 8.2-780 
4-Methyl-2-pentanone  108-10-1 4.20 1.696 0.06 2.34 1.6 0.18-20 7.0-780 
Vinyl butyrate  123-20-6 5.00 1.835 0.33 12.9 3.7 0.99-20 39-780 
n-Hexanal  66-25-1 6.65 1.590 0.26 10.2 1.5 0.78-50 30-1950 
Butyl acetate  123-86-4 7.00 1.915 0.20 7.80 0.6 0.6-20 23.4-780 
Ethyl isovalerate 3301-94-8 10.18 1.931 0.04 1.56 3.7 0.12-20 4.7-780 
n-Heptanal  111-71-7 10.58 1.492 0.30 11.7 3.5 0.9-50 35-1950 
Benzaldehyde  100-52-7 12.03 1.722 0.26 10.2 3.8 0.78-50 31-1950 
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Table 2. Mean (n=11) standard deviations of concentrations [ppb] of VOCs of interest. 
Compound Measurement time 
[min] 
Literature  
data 
0 20 40 60 80 100 120 140 
Background  Skin Emission  Breath and Skin Emission 
Acrolein  135±2 135±2 145±4 147±3 148±2 148±2 149±2 149±3 (a) 3.44 ppb 
(forearm)[21] 
Acetone  20.1±6 20.3±7 25.5±8.0 33.3±14 41.8±25 137±65 228±108 330±215 (a) 126 ppb[19] 
(b) 206 ppb (forearm)[21] 
2-Methylpropanal  18.7±1.4 18.5±0.7 21.6±1.1 22.9±1.4 23.3±1.6 23.8±1.9 23.2±2.3 23.2±2.2 (a) 2.23 ppb (forearm)[21] 
Ethyl formate  37.3±3 39±4 50.23.6 51.0±3.0 50±1.7 49±3.2 48±3.4 47±2.9  
2-Methyl-1-propanol  1.85±0.65 1.9±0.53 2.46±0.51 2.74±0.65 3.06±0.71 2.95±0.66 3.02±0.68 3.06±0.66  
3-methylbutanal  5.43±2.1 5.78±1.3 6.67±1.3 7.44±1.57 8.10±1.74 7.87±1.67 8.13±1.96 8.1±1.57 (a) 2.45 ppb (forearm) 
[21] 
2-Ethacrolein  0.35±0.4 0.39±0.29 1.75±1.9 3.02±3.1 3.40±4.65 4.52±2.94 6.53±5.1 7.76±6.26  
Ethyl propionate  2.10±1.2 2.51±1.31 3.93±0.64 4.81±1.05 5.7±1.9 6.16±3.25 6.36±4.23 6.29±4.0  
Acetic acid  66±15 70±8 98±34 121±51 133±62 141±68 147.5±70 155±60 (a)  105 ppb [19] 
2-pentanone  LOD LOD 0.24±0.25 0.47±0.45 0.76±0.54 1.04±0.78 0.96±0.75 0.99±0.77 (a) 1.17 ppb (forearm)[21] 
4-Methyl-2-
pentanone 
4.1±0.6 4.07±1.25 4.81±0.52 6.15±0.92 6.23±1.16 6.1±0.61 6.21±0.89 6.27±1.38  
Vinyl butyrate  0.81±0.49 0.89±0.51 2.95±1.34 4.52±1.89 4.79±1.48 5.30±0.97 5.39±0.51 5.58±0.62  
n-Hexanal  12±1.58 12.5±1.17 13.05±1.33 13.55±1.76 14.35±1.7 14.24±1.36 14.23±1.26 14.14±1.52 (a) 7.6 ppb (forearm)[21] 
Butyl acetate  0.3±0.43 0.43±0.73 1.05±1.95 1.28±1.18 1.32±1.18 0.89±0.8 0.87±0.6 0.45±0.9  
Ethyl isovalerate  0.08±0.16 0.12±0.2 2.04±2.0 3.87±1.7 4.60±2.3 5.50±1.9 6.18±1.6 6.77±1.4  
n-Heptanal  1.07±0.02 1.06±0.02 1.10±0.04 1.15±0.07 1.19±0.07 1.20±0.06 1.22±0.06 1.27±1.12 (a) 4.81 ppb (forearm)[21] 
Benzaldehyde  1.08±0.06 1.10±0.05 1.13±0.06 1.16±0.08 1.18±0.09 1.17±0.07 1.18±0.07 1.19±0.07 (a) 29.1 ppb (forearm) 
[21] 
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Figures captions 
Figure 1. Fragment of exemplary 2D GC-IMS chromatogram from the analysis of human-borne VOCs 
Figure 2. Mean concentration profiles of acetone, 2-ethacrolein, ethyl isovalerate, and vinyl butyrate. 
Pink – skin phase, magenta – skin and breath phase. 
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Highlights 
 Monitoring of volatiles emitted by humans by GC-IMS 
 The use of volatiles as potential markers of hidden humans 
 Instrumental detection of smuggled people  
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